Dr. Leslie Edward Broline is a Austin, Texas based Periodontics who is specialized in Periodontology. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 3508 Far West Blvd, Ste 330, Austin. Patients can reach him at 512-343-9488.
Dr. Leslie Edward Broline is specialized in that branch of dentistry which encompasses the prevention, diagnosis and treatment of diseases of the supporting and surrounding tissues of the teeth or their substitutes and the maintenance of the health, function and esthetics of these structures and tissues.
Complete Profile:
Dr. Leslie Edward Broline speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Name:
Dr. Leslie Edward Broline
Specialization:
Periodontics
Gender:
Male
Credentials:
DDS MS
Accepts Medicare Assignment:
May Accept
Practice Address:
3508 Far West Blvd, Ste 330, Austin, Texas, 78731-3041
Phone:
512-343-9488
Fax:
512-343-1062
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
PAC ID:
2163742008
Enrollment ID:
I20150518001079
NPI Number:
1154427029
NPI Enumeration Date:
16 Sep, 2006
NPI Last Update On:
08 Jul, 2007
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
3508 Far West Blvd, Ste 330 Austin, Texas
Zip:
78731-3041
Phone Number:
512-343-9488
Fax Number:
512-343-1062
Patients can reach Dr. Leslie Edward Broline at 3508 Far West Blvd, Ste 330, Austin, Texas or can call to book an appointment on 512-343-9488. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.